For questions or suggestions e-mail us at: ioerger@cs.tamu.edu
YYLLILAVVFERLAELVVAQRNARWSFAQGGKEFGRPHYVVMVILHTALLLGCVVEPWALHRPFIPWLGW PMLAVVVASQGLRWWCVKSLGKRWNTRVIVLPHATLVRRGPYRWMRHPNYVAVVAEGFALPLVHTAWLTA LVFTLANATLLTVRLRVENSVLGYI*
Operon Prediction Model: Genebank
Paralogs
species | id | gene | e-value | identity (len) | annotation |
M. tuberculosis H37Rv | Rv1139c | - | - | 100% (166) | hypothetical protein Rv1139c |
M. tuberculosis H37Rv | Rv2437 | - | 1e-07 | 39.19% (74) | hypothetical protein Rv2437 |
Closest Orthologs (e-value cutoff: 1e-4)
species | id | gene | e-value | identity (len) | annotation |
M. bovis AF2122 / 97 | Mb1171c | - | 9e-97 | 100.00% (166) | hypothetical protein Mb1171c |
M. gilvum PYR-GCK | Mflv_5141 | - | 4e-60 | 67.28% (162) | isoprenylcysteine carboxyl methyltransferase |
M. leprae Br4923 | - | - | - | - | - |
M. abscessus ATCC 19977 | - | - | - | - | - |
M. marinum M | MMAR_4314 | - | 6e-83 | 84.15% (164) | hypothetical protein MMAR_4314 |
M. avium 104 | MAV_1279 | - | 3e-79 | 80.61% (165) | isoprenylcysteine carboxyl methyltransferase (icmt) family |
M. smegmatis MC2 155 | MSMEG_0809 | - | 2e-52 | 64.78% (159) | isoprenylcysteine carboxyl methyltransferase |
M. thermoresistible (build 8) | - | - | - | - | - |
M. ulcerans Agy99 | MUL_0980 | - | 6e-82 | 82.93% (164) | hypothetical protein MUL_0980 |
M. vanbaalenii PYR-1 | Mvan_1195 | - | 4e-58 | 65.43% (162) | isoprenylcysteine carboxyl methyltransferase |
CLUSTAL 2.0.9 multiple sequence alignment Rv1139c|M.tuberculosis_H37Rv ---MYYLLILAVVFERLAELVVAQRNARWSFAQGGKEFGRPHYVVMVILH Mb1171c|M.bovis_AF2122/97 ---MYYLLILAVVFERLAELVVAQRNARWSFAQGGKEFGRPHYVVMVILH MMAR_4314|M.marinum_M MVSPYYLLILAIVVERLAELVIAQRNARWSFAQGGKEFGQPHYVVMVVLH MUL_0980|M.ulcerans_Agy99 MVSPYYLLILAIVVERLAELVIAQRNARWSFAQGGKEFGQPHYVVMVVLH MAV_1279|M.avium_104 ---MYYLLVLAVGLERVAELLVSTRNARWSFTQGGKEFGRSHYPVMVFIH Mflv_5141|M.gilvum_PYR-GCK -MFAYTLLIAAVAVERLAELVVSQRNLKWSKARGGVEFGAGHYPVMVVLH Mvan_1195|M.vanbaalenii_PYR-1 -MLAYTLLIAAVALERVAELVVSQRNLRWSRARGGVEFGATHYPLMVLLH MSMEG_0809|M.smegmatis_MC2_155 -MKAFTALVAAVAAERLAELVVSKRNLEWSKTHGGKEFGAGHYPVMVALH : *: *: **:***::: ** .** ::** *** ** :** :* Rv1139c|M.tuberculosis_H37Rv TALLLGCVVEPWALHRPFIPWLGWPMLAVVVASQGLRWWCVKSLGKRWNT Mb1171c|M.bovis_AF2122/97 TALLLGCVVEPWALHRPFIPWLGWPMLAVVVASQGLRWWCVKSLGKRWNT MMAR_4314|M.marinum_M SLLLVGCVIEPWALHRPFIPWLGWPMVAVLVLSQGLRWWCVTSLGRRWNT MUL_0980|M.ulcerans_Agy99 SLLLVGCVIEPWALYRPFIPWLGWPMVAVLVLSQGLRWWCVTSLGRRWNT MAV_1279|M.avium_104 TALLAGCLVEPWALHRPFLGWLGWPMLAVVAASQGLRWWCITTLGRRWNT Mflv_5141|M.gilvum_PYR-GCK TALLVGCLVE--ASHREFIPALGWTMFAVAIAAQALRWWCITTLGPQWNT Mvan_1195|M.vanbaalenii_PYR-1 TVLLAACLVE--AAHREFIPVLGWSMFALVVAAQGLRWWCITTLGHQWNT MSMEG_0809|M.smegmatis_MC2_155 TGLLAGAALE--ARRRRVRPALGRPMFAVVLAAQGLRWWCIKTLGPQWNT : ** .. :* * * . ** .*.*: :*.*****:.:** :*** Rv1139c|M.tuberculosis_H37Rv RVIVLPHATLVRRGPYRWMRHPNYVAVVAEGFALPLVHTAWLTALVFTLA Mb1171c|M.bovis_AF2122/97 RVIVLPHATLVRRGPYRWMRHPNYVAVVAEGFALPLVHTAWLTALVFTLA MMAR_4314|M.marinum_M RVIVLPDEPLVQKGPYRFLHHPNYVAVVAEGFALPLVHTAWVTALSFTVA MUL_0980|M.ulcerans_Agy99 RVIVLPDEPLAQKGPYRFLHHPNYVAVVAEGFALPLVHTAWVTALSFTVA MAV_1279|M.avium_104 RVIVLPQAPLVRDGPYRWLHHPNYVAVVAEGLALPLVHTAWLTAAVFTLA Mflv_5141|M.gilvum_PYR-GCK RVVVVPNAGRVTGGPYRFMSHPNYVAVVVEGIALPLVHTAWITALVFTVL Mvan_1195|M.vanbaalenii_PYR-1 RVVVVPGAGRVTGGPYRFLSHPNYVAVVVEGIALPLVHTAWVTALAFTLL MSMEG_0809|M.smegmatis_MC2_155 RVIVVPGATRVLAGPYRFLPHPNYVAVVAEGVALPLVGGAWRTALGFTIA **:*:* . ****:: ********.**.***** ** ** **: Rv1139c|M.tuberculosis_H37Rv NATLLTVRLRVENSVLGYI---- Mb1171c|M.bovis_AF2122/97 NATLLTVRLRVENSVLGYI---- MMAR_4314|M.marinum_M NAILLTVRLRVENSVLGYS---- MUL_0980|M.ulcerans_Agy99 NAILLTVRLRVENSVLGYS---- MAV_1279|M.avium_104 NAALLRVRLRVENSALGYT---- Mflv_5141|M.gilvum_PYR-GCK NAALLWTRISVENKALRTLTAAR Mvan_1195|M.vanbaalenii_PYR-1 NAALLWMRISVEDKALRTLHT-- MSMEG_0809|M.smegmatis_MC2_155 NALLLRTRIRVENDALRSLT--- ** ** *: **:..*